CN Patent

CN1370154A — 氨基噻唑衍生物及其作为crf受体配体的用途

Assigned to Sanofi Aventis France · Expires 2002-09-18 · 24y expired

What this patent protects

本发明涉及式(I)的化合物,其中R 1 、R 2 、R 3 、R 4 、R 5 、R 6 和R 7 如权利要求1所定义。所说的化合物对CRF受体具有亲和力。

USPTO Abstract

本发明涉及式(I)的化合物,其中R 1 、R 2 、R 3 、R 4 、R 5 、R 6 和R 7 如权利要求1所定义。所说的化合物对CRF受体具有亲和力。

Drugs covered by this patent

Patent Metadata

Patent number
CN1370154A
Jurisdiction
CN
Classification
—
Expires
2002-09-18
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis France
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.